Amalgamated Bank Vista Gen Therapeutics, Inc. Transaction History

Amalgamated Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$0.12 - $0.3 $198 - $495	1,650 Added 5.51%	31,571 $4,000
Q3 2022 Nov 09, 2022	BUY	$0.14 - $4.8 $55 - $1,905	397 Added 1.34%	29,921 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $726 - $1,428	-826 Reduced 2.72%	29,524 $26,000
Q1 2022 Jun 30, 2022	SELL	$1.14 - $2.09 $2,763 - $5,066	-2,424 Reduced 7.4%	30,350 $38,000
Q4 2021 Feb 15, 2022	SELL	$1.67 - $2.76 $531 - $877	-318 Reduced 0.96%	32,774 $64,000
Q3 2021 Oct 29, 2021	SELL	$2.62 - $3.45 $4,024 - $5,299	-1,536 Reduced 4.44%	33,092 $91,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $67,870 - $109,078	34,628 New	34,628 $109,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.